TotalMarketCap

Novo Nordisk A S

NVONYSE DenmarkHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$178.689 B

$40.36 -4.33%

Close of 6 Nov 2026

As of 6 Nov 2026, Novo Nordisk A S (NVO) has a market capitalization of $178.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #6AstrazenecaAZN$290.1B
  2. #7Abbott LaboratoriesABT$197.0B
  3. #8Novo Nordisk A SNVO$178.7B
  4. #9PfizerPFE$170.5B
  5. #10Vertex PharmaceuticalsVRTX$137.7B

What if Novo Nordisk A S were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,376.99

Per share 158× higher

Bitcoin $1.53T

$345.05

Per share 8.55× higher

Apple $5.02T

$1,132.76

Per share 28.1× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Novo Nordisk A S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.